Advancing Drug Discovery with Innovative Science and Technologies

The 2024 Medicinal Chemistry Gordon Research Conference will feature talks on the cutting edge of the discipline that include new technologies, therapeutic modalities, and molecules advancing drug discovery. Matt Volgraf of Septerna is responsible for the scientific program; please see the planned topics and contact the Chairs if you would like to submit a talk proposal. A preliminary program of speakers will be posted in November 2023.

In addition to the various scientific sessions, the conference will culminate with a “Late-Breaking Topics” session organized by Alex Cortez of Bristol Myers Squib. This session comprises late-breaking results on prioritized clinical candidates across therapeutic areas. Finally, the conference program will conclude on Thursday evening with the Keynote address organized by the Chair.

We strongly encourage attendees to submit poster presentations on any aspect of Medicinal Chemistry as the poster sessions are an essential outlet for thoughtful discussion and interaction among the conferees. This year, the poster sessions will be organized by H. Rachel Lagiakos of Schrödinger.

The 2024 Medicinal Chemistry GRC will continue a tradition of outstanding science presented in a relaxed atmosphere offering a variety of social activities. Vice Chair-Elect Emily Peterson of Novartis will organize social events for the week, including hikes of Mt. Kearsarge and Mt. Cardigan, cycling, frisbee golf, cruising Lake Sunapee, volleyball, softball, soccer, a golf scramble, and a charity fundraiser.

As we look forward to another amazing conference in 2024, on behalf of myself, the Vice Chair, and the Vice Chair-Elect, we welcome your application. We encourage applications by April 1, 2024, and the submission of any poster abstracts by April 15, 2024, to facilitate the admissions process. We particularly encourage applications from those of diverse backgrounds and scientific perspectives, and those who submit high-quality poster applications are given priority for admission considerations.

Prospective applicants are expected to share unpublished or undisclosed data, along with any undisclosed chemical structures, within their poster presentations.

Solicitations are not welcomed.

Thank you for your interest in the Medicinal Chemistry GRC!

Erin F. DiMauro Merck & Co., Inc.

Chair, 2024 Medicinal Chemistry GRC